HEALTHCARE professionals
should ensure that the care given
to diabetes type II patients is suited
to their individual needs, according
to new guidelines from the UK
National Institute for Health and
Care Excellence (NICE).
Personal preferences,
comorbidities, polypharmacy
risks and the extent to which an
individual can benefit from an
intervention in the context of
multimorbidity should all be taken
into account, the guidelines say.
See www.nice.org.uk for details.The above article was sent to subscribers in Pharmacy Daily's issue from 04 Dec 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Dec 15
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.